ADHD Targets and Treatments
neuroscienceCME WebcastPremiere Date: Monday, February 12, 2018
This activity offers CE credit for:%>
- Physicians (CME)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Tuesday, February 12, 2019
Note: Credit Is No Longer Available
|Scott H. Kollins, PhD
Chief Medical Officer, Holmusk
Adjunct Professor of Psychiatry and Behavioral Science
Duke University School of Medicine
This video is a replay of a plenary session from the 10th Annual Chair Summit Master Class for Neuroscience Professional Development held in New Orleans, LA on November 16-18, 2017.
At the end of this CE activity, participants should be able to:
- Recognize the early presentation of ADHD to accurately diagnose patients with ADHD
- Utilize evidence-based treatment in patients with ADHD
- Use shared decision-making with patients and family members to develop strategies to hep manage the impact of ADHD on daily and long-term functioning
This activity is supported by an educational grant from Sunovian Pharmaceuticals Inc.
Physicians, physician assistants, nurse practitioners, pharmacists, certified case managers, social workers, and other nonphysical healthcare professionals with an interest in psychiatry, neurology, and the neurosciences.
CME Credit (Physicians):
CME Outfitters, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of the CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Kollins reports that he receives grants from the National institute of Health (NIH). He receives research support from Akili Interactive Labs; KemPharm, Inc.; Medgenics, Inc.; Rhodes Pharmaceuticals LP.; Shire; and Sunovian Pharmaceuticals Inc. He is a consultant for Akili Interactive Labs; Alcobra Pharma; Jazz Pharmaceuticals Inc.; KemPharm, Inc.; Medgenics, Inc.; Otsuka America Pharmaceutical, Inc.; Rhodes Pharmaceuticals LP.; Shire; and Sunovian Pharmaceuticals Inc.
Howard Bliwise, MD (peer reviewer) has no disclosures to report.
Kashemi D. Rorie, PhD (planning committee) has no disclosures to report.
Daniela V. DiBiase, MS (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).